.alpha.-Amylase inhibitor from a streptomycete and process for its preparation
AssigneeHoechst Aktiengesellschaft
InventorsVolker Oeding, Werner Pfaff, Laszlo Vertesy, Hans-Ludwig Weidenmuller
Life of this patent
Estimating the term…
Abstract
Inhibitor for the glycoside hydrolases of the digestive tract, more particularly of the pancreatic .alpha.-amylase produced by fermentation of the specific microorganism Streptomyces tendae, strain 4158, as well as the variants and mutants thereof, the microbe strain per se and processes for the isolation of the inhibitor and for its purification.
Claims1
Peptidic glycoside hydrolase inhibitor obtained by cultivating Streptomyces tendae 4158 (ATCC no. 31210) and isolating the inhibitor from the culture, said inhibitor having a molecular weight in the range of from 5,000 to 10,000, an absorption maximum in the ultraviolet light at 276 nm, an isoelectric point of 4.4 and the following amino acid composition:
- ______________________________________ aspartic acid 5-6 glycine 5-6 threonine 5-6 alanine 5-6 serine 3-5 cysteine 3-4 glutamic acid 5-6 valine 5-6 proline 2-3 isoleucine 1-2 leucine 3-4 lysine 0-1 tyrosine 4-5 arginine 2-3 phenylalanine 0-2 tryptophan 1-2 histidine 1-2 ______________________________________
Dependencies are inferred from the claim text.